Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 11,244,000 | 12,205,000 | 13,170,000 | 10,735,000 | 10,606,000 |
| Cost of Goods | 3,138,000 | 3,756,000 | 3,412,000 | 2,992,000 | 2,889,000 |
| Gross Profit | 8,106,000 | 8,449,000 | 9,758,000 | 7,743,000 | 7,717,000 |
| Operating Expenses | 5,837,000 | 6,819,000 | 5,973,000 | 6,031,000 | 5,256,000 |
| Operating Income | 2,269,000 | 1,630,000 | 3,785,000 | 1,712,000 | 2,461,000 |
| Interest Expense | 178,000 | 38,000 | 227,000 | 87,000 | 213,000 |
| Other Income | -88,000 | -2,509,000 | -48,000 | -201,000 | -90,000 |
| Pre-tax Income | 2,003,000 | -917,000 | 3,510,000 | 1,424,000 | 2,158,000 |
| Income Tax | 420,000 | -348,000 | 680,000 | 230,000 | 481,000 |
| Net Income Continuous | 1,594,000 | -807,000 | 2,828,000 | 1,237,000 | 1,719,000 |
| Net Income Discontinuous | 26,000 | 13,000 | -20,000 | 2,707,000 | 174,000 |
| Minority Interests | -6,000 | -7,000 | -6,000 | -4,000 | -21,000 |
| Net Income | $1,614,000 | $-801,000 | $2,802,000 | $3,940,000 | $1,872,000 |
| EPS Basic Total Ops | 1.34 | -0.66 | 2.30 | 3.22 | 1.52 |
| EPS Basic Continuous Ops | 1.32 | -0.67 | 2.32 | 1.02 | 1.38 |
| EPS Basic Discontinuous Ops | 0.02 | 0.01 | -0.02 | 2.20 | 0.14 |
| EPS Diluted Total Ops | 1.34 | -0.66 | 2.30 | 3.22 | 1.52 |
| EPS Diluted Continuous Ops | 1.32 | -0.67 | 2.32 | 1.01 | 1.38 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.01 | -0.02 | 2.20 | 0.14 |
| EBITDA(a) | $2,716,000 | $-341,000 | $4,198,000 | $1,889,000 | $2,770,000 |